BACKGROUND: About 75% of people living with HIV/AIDS (PHAs) who need antiretroviral therapy have no access to these drugs in low-income countries. OBJECTIVE: To investigate the barriers to use of ART in Rakai district of Uganda. METHODS: We interviewed 38 key informants and 384 PHAs. Data was collected on: education/mobilization for ART, sources of information for ART, beliefs regarding ART, social support, use of alternative medicine, stigma/discrimination towards PHAs, distance to ART centres, transport costs to ART centres, waiting time, and on suggestions as how to improve the use of ART. RESULTS: The major barriers mentioned regarding use of ART included: inadequate mobilization, long waiting time at ART treatment centres, high cost of transport to reach ART centres, stigma/discrimination towards PHAs and inadequate number of health workers to attend to PHAs. CONCLUSIONS: Access to antiretroviral therapy could be ameliorated by: improving community education using innovative approaches such as through music, dance and videos, increasing the number of providers who are able to provide ART as through engagement of non health professionals in ART care, bringing ART nearer to where people live and instituting measures aimed at reducing stigma/discrimination such as through involvement of PHAs in demystisfying HIV/AIDS.
BACKGROUND: About 75% of people living with HIV/AIDS (PHAs) who need antiretroviral therapy have no access to these drugs in low-income countries. OBJECTIVE: To investigate the barriers to use of ART in Rakai district of Uganda. METHODS: We interviewed 38 key informants and 384 PHAs. Data was collected on: education/mobilization for ART, sources of information for ART, beliefs regarding ART, social support, use of alternative medicine, stigma/discrimination towards PHAs, distance to ART centres, transport costs to ART centres, waiting time, and on suggestions as how to improve the use of ART. RESULTS: The major barriers mentioned regarding use of ART included: inadequate mobilization, long waiting time at ART treatment centres, high cost of transport to reach ART centres, stigma/discrimination towards PHAs and inadequate number of health workers to attend to PHAs. CONCLUSIONS: Access to antiretroviral therapy could be ameliorated by: improving community education using innovative approaches such as through music, dance and videos, increasing the number of providers who are able to provide ART as through engagement of non health professionals in ART care, bringing ART nearer to where people live and instituting measures aimed at reducing stigma/discrimination such as through involvement of PHAs in demystisfying HIV/AIDS.
Entities:
Keywords:
ART access; HIV/AIDS; Stigma/discrimination; Uganda; task-shifting
Authors: Badara Samb; Francesca Celletti; Joan Holloway; Wim Van Damme; Kevin M De Cock; Mark Dybul Journal: N Engl J Med Date: 2007-12-13 Impact factor: 91.245
Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245
Authors: C D Batson; M P Polycarpou; E Harmon-Jones; H J Imhoff; E C Mitchener; L L Bednar; T R Klein; L Highberger Journal: J Pers Soc Psychol Date: 1997-01
Authors: Alexander C Tsai; Sheri D Weiser; Wayne T Steward; Nozmo F B Mukiibi; Annet Kawuma; Annet Kembabazi; Conrad Muzoora; Peter W Hunt; Jeffrey N Martin; David R Bangsberg Journal: AIDS Behav Date: 2013-01
Authors: Paul Mee; Mark A Collinson; Sangeetha Madhavan; Chodziwadziwa Kabudula; Francesc Xavier Gómez-Olivé; Kathleen Kahn; Stephen M Tollman; James Hargreaves; Peter Byass Journal: Glob Health Action Date: 2014-11-20 Impact factor: 2.640
Authors: Jacob Bor; Calvin Chiu; Shahira Ahmed; Ingrid Katz; Matthew P Fox; Sydney Rosen; Manisha Yapa; Frank Tanser; Deenan Pillay; Till Bärnighausen Journal: Trop Med Int Health Date: 2018-01-10 Impact factor: 3.918
Authors: Paul Mee; Mark A Collinson; Sangeetha Madhavan; Elisabeth Dowling Root; Stephen M Tollman; Peter Byass; Kathleen Kahn Journal: J Glob Health Date: 2014-06 Impact factor: 4.413